Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy

Not yet recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Epilepsies, Partial
Interventions
DRUG

Zonisamide

This is a real-world study,so we prospectively enrolled patients with focal epilepsy suitable for taking zonisamide as an add-on medication

Trial Locations (10)

310005

Hangzhou Children's Hospital, Hangzhou

310009

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

313002

Huzhou Third People's Hospital, Huzhou

314099

Jiaxing Second hospital, Jiaxing

315012

Ningbo Women And Children's Hospital, Ningbo

315048

Ningbo Medical center Lihuili hospital, Ningbo

315499

Yuyao People's hospital, Yuyao

321016

Jinhua Second hospital, Jinhua

322099

The Fourth Affilicated Hospital of Zhejiang University School of Medicine, Jinhua

323050

Lishui People's Hospital, Lishui

All Listed Sponsors
collaborator

Hangzhou Children's Hospital

UNKNOWN

collaborator

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

OTHER

collaborator

Jinhua Second Hospital

UNKNOWN

collaborator

Ningbo Medical Center Lihuili Hospital

OTHER_GOV

collaborator

Ningbo Women & Children's Hospital

OTHER

collaborator

Yuyao People's Hospital

OTHER

collaborator

Huzhou Third People's Hospital

OTHER

collaborator

The Second Affiliated Hospital of Jiaxing University

OTHER

collaborator

Lishui Country People's Hospital

OTHER

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT06374966 - Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy | Biotech Hunter | Biotech Hunter